Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Has the Xerostomia Therapeutics Market Growth Performance Trended Historically, And What Lies Ahead?
The market size for xerostomia therapeutics has been on a consistent growth trajectory in the past few years. It’s projected to increase from $2.14 billion in 2024, reaching $2.24 billion in 2025, with a compound annual growth rate (CAGR) of 4.7%. The upward trend during the historical period is a result of higher occurrences of xerostomia among the elderly, advancements in the research and development of effective xerostomia products, heightened awareness of products related to xerostomia, an escalation in medical conditions, and a growing prevalence of chronic diseases.
Expectations are high for the xerostomia therapeutics market to experience consistent growth in the upcoming years. The market is anticipated to reach $2.69 billion by 2029, with a compound annual growth rate (CAGR) of 4.7%. The growth during the expected period can be linked to factors such as the broad accessibility of affordable drugs, the increasing incidence of oral health disorders, heightened awareness among medical professionals, government-led initiatives, and an uptick in medication usage. Key trends during this projected period include the emergence of artificial saliva and saliva substitutes, advances in technology and product innovation, the rise of personalized and targeted treatments, the growing use of telehealth and remote monitoring, and the popularity of non-invasive procedures.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15700&type=smp
Which Factors and External Forces Are Driving Demand in the Xerostomia Therapeutics Market?
The forward movement of the xerostomia therapeutics market can be attributed to the growing utilization of chemotherapy in the treatment for cancer. How chemotherapy works in treating cancer is by deploying potent drugs to eliminate or hinder the expansion of cancer cells. The primary reason for this growing acceptability of chemotherapy in cancer treatment is its efficiency in precisely targeting cancer cells and eliminating them anywhere in the body. The solutions provided by xerostomia therapeutics usually revolve around the use of drugs that stimulate saliva or mouthwashes that aid in saliva production and enhance the sense of taste, thus easing the process of eating and facilitating proper nutrition. For example, recent data from the National Cancer Institute, a US government agency, suggests that as of January 2022, there are about 18.1 million individuals who have overcome cancer in the United States, representing 5.4% of the total American population. Projections indicate that by 2032, the global figure for cancer survivors would rise by 24.4% from the present estimate, reaching an approximate 22.5 million. Consequently, the growing inclination towards chemotherapy for cancer treatment is fueling the expansion of the xerostomia therapeutics market.
Which Segments in the Xerostomia Therapeutics Offer the Most Growth?
The xerostomia therapeutics market covered in this report is segmented –
1) By Type: Artificial Saliva Or Saliva Substitutes, Salivary Stimulants
2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Drug Stores, Mail Order Pharmacies, Hypermarkets And Supermarkets
3) By End-User: Adult, Pediatric
Subsegments:
1) By Artificial Saliva Or Saliva Substitutes: Oral Sprays, Gels, Lozenges, Mouthwashes
2) By Salivary Stimulants: Prescription Drugs, Over-The-Counter (Otc) Products, Chewing Gums And Lozenges
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=15700&type=smp
What Are the Fastest-Growing Geographies in the #Which Factors and External Forces Are Driving Demand in the Xerostomia Therapeutics Market?# Market?
North America was the largest region in the xerostomia therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the xerostomia therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Which Cutting-Edge Market Trends Are Expected to Drive theXerostomia Therapeutics Market’s Growth?
Key players in the xerostomia therapeutics market are innovating patient-centric, non-invasive treatments like oral sprays, responding to the increasing need for easily usable and effective remedies for dry mouth. Oral sprays enable targeted application to the affected parts of the mouth, supplying efficient hydration and lubrication exactly where it’s needed. For example, in July 2023, India-based K Pharmaceuticals introduced Aquoral, an oral spray scientifically tested to alleviate dry mouth, or xerostomia. Various conditions, such as medications and illnesses, can trigger this condition, potentially causing discomfort, problems with chewing and swallowing, and oral health issues. Aquoral provides enduring relief for up to six hours by creating an extended protective coating in the oral cavity, reducing moisture loss and improving comfort. Unlike conventional water-based treatments that necessitate regular reapplication, Aquoral employs a patented technology using Oxidized Glycerol Triesters (OGT), a plant-sourced, lipid-based compound that provides superior shielding.
View the full report here:
https://www.thebusinessresearchcompany.com/report/xerostomia-therapeutics-global-market-report
What Are the Key Elements That Define the Xerostomia Therapeutics Market?
Xerostomia therapeutics refer to treatments and medications used to manage dry mouth; a condition characterized by reduced saliva production. These therapies aim to alleviate symptoms such as difficulty swallowing and tasting, as well as prevent dental issues.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15700
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
